Leukemia: all 5,475 studies
Page 44 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00769522Phase 3
- Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00769327Phase 2
- FAU in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00769288Phase 1
- A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell LymphomasTerminatedNCT00768339Phase 1/2
- Aerobic and Strengthening Exercise for Acute LeukemiaCompletedNCT00766311Not applicable
- Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT00764907Phase 3
- A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)CompletedNCT00764231Phase 2
- Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveCompletedNCT00763763Phase 2
- Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid LeukemiaCompletedNCT00762632Phase 1/2
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple MyelomaCompletedNCT00761722Phase 1
- Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)WithdrawnNCT00758693Phase 2
- A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related DonorsTerminatedNCT00756912Phase 1
- Nilotinib Pre and Post Allogeneic Stem Cell TransplantationCompletedNCT00750659Phase 2
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialCompletedNCT00750009Phase 3
- A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)CompletedNCT00749502Phase 1
- Assess the Oral Bioavailability of New ABT-263 FormulationsCompletedNCT00743028Phase 1
- Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.TerminatedNCT00742495Phase 1/2
- Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00742144Phase 1
- Stem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersStatus unknownNCT00740467Phase 2
- Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive ChemotherapyCompletedNCT00739388Phase 2
- Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLLCompletedNCT00738829Phase 1/2
- Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00735930Phase 1
- Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic SyndromeCompletedNCT00732316Phase 2
- Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid LeukemiaWithdrawnNCT00732186Phase 1
- Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell LymphomaWithdrawnNCT00730652Phase 1
- Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction TherapyStatus unknownNCT00728520Phase 2
- Oral Clofarabine for Acute Myeloid LeukemiaCompletedNCT00727766Phase 1
- The Effectiveness of the Neutropenic Diet in Pediatric Oncology PatientsCompletedNCT00726934Not applicable
- Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantTerminatedNCT00725062Phase 1
- Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)TerminatedNCT00724360Phase 2
- Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic LeukaemiaCompletedNCT00723346Phase 1/2
- Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)TerminatedNCT00720850Phase 2
- A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid MalignanciesCompletedNCT00719836Phase 1/2
- Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2Status unknownNCT00718250Phase 1
- Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantCompletedNCT00716911Not applicable
- Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE StudyStatus unknownNCT00715637Phase 3
- 8-Chloro-Adenosine in Chronic Lymphocytic LeukemiaCompletedNCT00714103Phase 1
- Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral DysfunctionCompletedNCT00713505Not applicable
- Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic MalignanciesCompletedNCT00710528Phase 1
- Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive LeukemiaStatus unknownNCT00709215Phase 1/2
- Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00707083Phase 3
- Decitabine and Bortezomib in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00703300Phase 1
- Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant SurvivorsCompletedNCT00701844Not applicable
- BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid LeukaemiaCompletedNCT00701766Phase 2
- Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/LymphomaTerminatedNCT00699296Phase 2
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell TransplantCompletedNCT00697684Phase 1
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic MalignanciesCompletedNCT00697671Phase 1
- Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00694590Phase 1
- Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins LymphomaCompletedNCT00693602Phase 1
- Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)CompletedNCT00689000Phase 1/2
- Total Marrow Irradiation for Refractory Acute LeukemiaCompletedNCT00686556Phase 1
- Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00686218Phase 1
- Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)CompletedNCT00682305Phase 2
- Allogeneic Transplantation for Pediatric Leukemias With Unrelated DonorsStatus unknownNCT00679536Phase 1/2
- Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute LeukemiaCompletedNCT00678275Phase 3
- Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or MyelodysplasiaCompletedNCT00677859Phase 1
- A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)WithdrawnNCT00676871Phase 1/2
- A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic SyndromeTerminatedNCT00676728Phase 1
- Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic LeukemiaStatus unknownNCT00675870Phase 2
- Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell TransplantTerminatedNCT00674427Phase 1
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following TransplantationTerminatedNCT00672152Phase 1
- Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid LeukemiaCompletedNCT00671697Phase 1
- Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaTerminatedNCT00671112Phase 1
- New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic LeukemiaWithdrawnNCT00670150Phase 2
- Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMMLTerminatedNCT00669890Phase 1
- Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete RemissionCompletedNCT00667927Phase 1
- Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)TerminatedNCT00666497Phase 2
- Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and LeukemiaCompletedNCT00665990Phase 1
- Phase 1 Study of Terameprocol (EM-1421) in Patients With LeukemiaTerminatedNCT00664677Phase 1
- Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia SurvivorsCompletedNCT00664131
- Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to GleevecCompletedNCT00661180Phase 2
- Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological MalignanciesCompletedNCT00660920Phase 1
- Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid LeukemiaTerminatedNCT00660036Phase 1
- Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional CytarabineTerminatedNCT00655395Phase 1/2
- Velcaflagida in Relapsed or Refractary Acute Myeloid LeukemiaCompletedNCT00651781Phase 1/2
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
- Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic LeukemiaTerminatedNCT00646165Phase 1
- Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic LeukemiaCompletedNCT00645606Phase 3
- Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic LeukemiaTerminatedNCT00643240Phase 1
- Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic MalignanciesCompletedNCT00642031Phase 1
- Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic SyndromesCompletedNCT00641030Phase 1
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid TumorsCompletedNCT00640796Phase 1
- Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00640523Phase 2
- A Study of ARRY-520 in Patients With Advanced Myeloid LeukemiaCompletedNCT00637052Phase 1/2
- Everolimus (RAD001) in Elderly Patients With Acute Myeloid LeukemiaStatus unknownNCT00636922Phase 1
- Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00634881Phase 1/2
- Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to TreatmentCompletedNCT00632255
- Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or LymphomaCompletedNCT00631579Phase 2
- Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia PatientsTerminatedNCT00631059Not applicable
- Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)Status unknownNCT00628238Phase 2
- Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerCompletedNCT00627666Phase 2
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT00624936Phase 1
- Antifungal Prophylaxis in Pediatric Acute LeukemiaStatus unknownNCT00624143Phase 3
- Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin LymphomaCompletedNCT00621452Phase 1
- Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell TransplantationCompletedNCT00620633Phase 1
- Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric MalignanciesCompletedNCT00619879
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced LeukemiaTerminatedNCT00618696Phase 1
- Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00618501Phase 2
- Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's LymphomaCompletedNCT00614042Phase 1
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00613457Phase 3